Studies have confirmed that Sp1 regulates the expression of c-Met by enhancing its transcription, thereby promoting tumor cell proliferation, migration, and drug resistance, substantially influencing tumorigenesis and progression (26–28). The gene discussed is MET; the disease is neoplasm.